HCA Stock - HCA Healthcare, Inc.Fundamentals & Analysis

Services-General Medical & Surgical Hospitals, NEC

HCA Healthcare, Inc. (HCA) — Executive Summary HCA Healthcare, Inc. operates a large U.S. hospital and healthcare services network and presents as a capital‑intensive, cash‑generative company with strong multi‑year EPS compounding and steady revenue growth. The company’s multi‑year growth profile is a clear strength: 5‑year EPS compounded at 19.20% and revenue per share rising at a 7.51% CAGR, wit

HCA Healthcare, Inc.

Services-General Medical & Surgical Hospitals, NEC
Stock Price
$389.41
+$7.22 (+1.89%)
Jul 27, 2026
Debt to Equity
72.0%
ROE
14.1%
PE Ratio
8.69
EPS (Diluted)
$21.16

Hca Healthcare Inc (HCA) Fundamental Analysis

HCA Healthcare, Inc. (HCA) — Executive Summary

HCA Healthcare, Inc. operates a large U.S. hospital and healthcare services network and presents as a capital‑intensive, cash‑generative company with strong multi‑year EPS compounding and steady revenue growth.

The company’s multi‑year growth profile is a clear strength: 5‑year EPS compounded at 19.20% and revenue per share rising at a 7.51% CAGR, with the most recent revenue‑per‑share level at $321.47 and year‑over‑year growth of 7.1% (see EPS Diluted & Revenue per Share and Revenue & EPS Growth).

Profitability on a net basis has been durable, with a reported net margin around 11.84% and a trailing‑twelve‑month return on equity that stepped up to 14.1% (2021), supporting the company’s ability to convert earnings to shareholder returns (see Profit Margin Trends and Return on Equity (ROE)).

Cash quality also looks strong on historical metrics: operating cash flow has exceeded net income on a multi‑period basis (cash conversion ratio 1.9561), and operating cash flow TTM was reported at $5.45B in the available series (see Earnings Quality Analysis).

Areas of Concern

Notable areas of concern include near‑term liquidity and allocation of capital. The current ratio is below 1.0 at 0.8335, indicating tighter short‑term liquidity (see Strategic Capital Allocation).

Financing cash flow has shown increasing outflows, with Financing Cash Flow (TTM) moving to –$8.55B by 2025‑12‑31, which represents a pronounced increase in financing outlays versus earlier periods (see Strategic Capital Allocation).

There is also a divergence in the most recent comparable observations between net income ($6.96B TTM) and the most recent reported operating cash flow ($5.45B), narrowing the previously favorable cash‑conversion relationship (see Revenue & Net Income and Earnings Quality Analysis).

Key Fundamentals to Watch

  • Trend of operating margin — most recent: −3.2%
  • Trends in operating cash flow vs. net income — cash conversion ratio historically 1.9561, recent OCF $5.45B vs. net income $6.96B
  • Current ratio — 0.8335
  • Financing cash flow magnitude — −$8.55B TTM
  • Revenue‑per‑share growth — 7.1% latest
  • P/E multiple trend — ~8.69x

See Profit Margin Trends, Earnings Quality Analysis, Strategic Capital Allocation, Revenue & EPS Growth, and Price-to-Earnings (PE) Ratio Trend for the supporting series.

Revenue and Growth

Revenue Trend

Revenue & Net Income

The foundation of business quality and long-term value creation

Revenue & Net Income Growth

Recent Revenue Trends

HCA Healthcare, Inc.'s recent quarterly revenue has been concentrated around the high‑teen billions. Quarterly receipts were $19.08B in 2025‑03‑31 and $19.11B in 2026‑03‑31, with intervening quarterly reports at about $20.14B (2024‑09‑30). Reported period totals labeled at year‑end show larger aggregated figures — $56.52B (2025‑12‑31), $50.46B (2024‑12‑31), and $64.97B (2023‑12‑31) — while the most recent quarter remains near $19.1B.

Net Income Trends

Net income for HCA Healthcare, Inc. has trended upward in the most recent quarterly observations, rising from $1.59B (2024‑03‑31) to $1.65B (2025‑06‑30) and $1.86B (2026‑03‑31). There are earlier, larger year‑end net income observations in the dataset (for example $4.69B at 2021‑12‑31 and $3.09B at 2020‑12‑31) that stand out relative to typical quarterly results. The most recent quarterly revenue was $19.11B. The most recent quarterly net income was $1.86B.

Why Growth Matters

Consistent revenue and earnings growth are the lifeblood of successful long-term investments. Companies that can grow their top line (revenue) and bottom line (net income) over many years demonstrate they have products or services customers value and are willing to pay for repeatedly.

Revenue Growth shows whether the company is expanding its market reach, gaining market share, or successfully launching new products.Net Income Growth demonstrates the company can convert that revenue into actual profits while managing costs effectively.

Look for steady, sustainable growth rather than erratic spikes. The best businesses compound earnings year after year, creating tremendous value for shareholders over time. Companies that can grow earnings faster than revenue are improving their profitability—a sign of operational excellence and competitive strength.

HCA Healthcare, Inc. (HCA) quarterly revenue and net income trend analysis showing historical financial performance over multiple years. Interactive chart displaying revenue growth, net income trends, and profitability patterns for HCA stock with quarterly and annual data points.

EPS Diluted & Revenue per Share

Per-share earnings and revenue — the shareholder's view of growth

Why Per-Share Metrics Matter

Total revenue and net income can grow simply because a company issues more shares or makes acquisitions. Per-share metrics cut through that noise — they show how much value each single share of stock is generating, which is what actually matters to shareholders.

Revenue per Share (split-adjusted) tells you how much revenue the business generates for every share outstanding. Growing revenue per share means the company is either expanding the business or shrinking the share count — both shareholder-friendly signals.EPS Diluted (split-adjusted) captures bottom-line earnings per share after accounting for all dilutive instruments such as stock options and convertible debt.

The most powerful signal is when both lines rise together over many years. If revenue per share grows but EPS lags, margins are being squeezed. If EPS grows faster than revenue per share, the company is becoming more profitable — a hallmark of businesses with durable competitive advantages. Watch for share buybacks, which can mechanically lift EPS even if total earnings are flat.

HCA Healthcare, Inc. (HCA) EPS diluted and revenue per share trend showing historical per-share earnings and revenue performance over time.

Revenue & EPS Growth

Year-over-year growth rates for revenue and earnings per share

Reading the Growth Rate Chart

This chart converts the absolute per-share figures into year-over-year percentage changes, making it easy to see whether growth is accelerating, decelerating, or reverting to trend — regardless of the company's absolute size.

Revenue per Share Growth (1-year, split-adjusted) measures how quickly the top line is expanding on a per-share basis. Sustained positive growth signals that the company continues to win customers and grow its addressable market.EPS Diluted Growth (1-year, split-adjusted) measures how quickly earnings are compounding for each shareholder. When EPS growth consistently outpaces revenue growth, operating leverage and margin expansion are at work.

Look for consistency, not just magnitude. A company that reliably grows EPS 10–15% per year is far more valuable than one that alternates between 50% spikes and deep contractions. Negative EPS growth during a period of positive revenue growth is a red flag — costs are rising faster than sales. Quarters where both lines converge near zero or go negative deserve close scrutiny.

HCA Healthcare, Inc. (HCA) year-over-year revenue per share and EPS diluted growth rate trend analysis showing historical growth performance.

Revenue Analysis

Revenue Waterfall Analysis

How revenue converts to net income for the most recent annual period

HCA Healthcare, Inc. (HCA) revenue waterfall chart showing the breakdown from total revenue to net income. Displays cost of goods sold, operating expenses, selling and administrative costs, research and development expenses, tax expenses, and final net income for HCA. Annual financial statement waterfall analysis showing profit margin components and expense structure.

Period Information

Report Type: Annual (10-K)

Period: Apr 2025 to Mar 2026

Revenue Sources

Revenue composition by disclosure category for the latest period

Revenue Streams

Patient services revenues generated by hospital inpatient care, including medical/surgical services, intensive care, cardiac care, diagnostic services and emergency services.

Patient services revenues generated by outpatient services provided by hospitals and outpatient facilities, including outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, physical therapy, diagnostic and imaging services, and radiation and oncology therapy.

Revenues from behavioral health services delivered through behavioral hospitals, inpatient, partial hospitalization and outpatient settings.

Revenues from rehabilitation services provided through rehabilitation hospitals and hospital rehabilitation units.

Revenues from ambulatory surgery centers and freestanding endoscopy centers for surgical procedures and related services.

Revenues from physician services reimbursed under fee schedules (Physician Fee Schedule) and related clinician services.

Revenues from home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers and other ancillary and post-acute services.

Payments under government programs, including Medicare, Medicaid and TRICARE, for inpatient and outpatient services and for portions of deductible and coinsurance amounts of beneficiaries that are uncollectable.

Payments from managed care plans (including Medicare Advantage/Managed Medicare and managed Medicaid), private insurers, employer-sponsored plans and health plans offered through federal and state Exchanges.

State-directed, supplemental and disproportionate share hospital (DSH) payments under Medicaid and other state programs that are separate from base reimbursements.

Revenues from value-based and alternative payment arrangements, including accountable care organizations, bundled payment models and CMS Innovation Center demonstration projects (including programs that provide shared savings or require shared losses).

Management and administrative services provided by affiliates to health care facilities (explicitly described management services such as supply contracting, equipment purchasing/leasing, accounting, clinical systems, reimbursement assistance, construction planning, IT systems, legal counsel, human resources and internal audit).

Customer Profile

Federal government programs and agencies as payers, specifically Medicare.

State governments and state-administered Medicaid programs as payers and sources of supplemental and state-directed payments.

Managed care plans, including Medicare Advantage plans (Managed Medicare), Medicaid managed care organizations (Managed Medicaid), HMOs and PPOs.

Private health insurers and other commercial managed care and employer-sponsored group purchasers of health care services.

Individual patients, including uninsured and self-pay patients who pay directly and patients with coinsurance, deductibles or other cost-sharing responsibilities.

International managed care and insurer entities for services provided in England.

Military health program (TRICARE) as a payer for active duty and eligible beneficiaries.

Physicians and other health care professionals as referral sources and as parties to employment, contractual and joint-venture arrangements.

Geographic Reach

Operates hospitals and other health care facilities in nineteen U.S. states and in England.

Health care facility footprint includes general acute care hospitals, behavioral hospitals, rehabilitation hospitals, freestanding ambulatory surgery centers and freestanding endoscopy centers across those jurisdictions.

Facilities and operations are concentrated in certain states, with explicit note of heavy concentration in Florida and Texas.

Distribution & Sales Channels

Delivery of services primarily through owned, managed or operated facilities, including general acute care hospitals, behavioral and rehabilitation hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, physician practices, diagnostic and imaging centers, home health and hospice agencies, and other outpatient and ancillary sites.

Most ASCs operated through partnerships or limited liability companies with majority ownership typically held by an HCA affiliate.

Revenue realization through negotiated contracts with third-party payers (managed care contracts) that are typically negotiated for terms between one and three years.

Direct patient billing for uninsured and self-pay patients, including application of charity care policies and uninsured discounts where applicable.

Provider participation and billing under federal and state programs administered through Medicare Administrative Contractors and similar contractors for claim processing and audits.

Use of enterprise-level management services and national supply contracts provided by affiliates to support facility operations and purchasing.

Recurring vs Transactional Revenue Characteristics

Revenues are primarily reimbursement-based, derived from ongoing payer programs (Medicare, Medicaid, managed care plans, private insurers) and from ongoing patient service delivery at facilities, indicating a recurring reimbursement model tied to patient volumes and payer arrangements.

Managed care contracts have explicit multi-year terms indicating recurring contractual relationships with payers.

Certain payments are periodic or programmatic (e.g., state supplemental payments, DSH payments, value-based shared savings or repayments) and may be subject to annual or periodic approval or recalculation.

Revenue recognition and cash flows are affected by regulatory and administrative processes that include annual cost reports, prior authorization requirements, post-payment audits and reviews (including RACs, UPICs and other integrity contractors), and appeal processes, which can adjust amounts ultimately determined to be due.

Alternative payment models and CMS programs may provide performance-based or delayed payments (for example, shared savings paid after performance periods), reflecting both recurring and contingent payment characteristics.

Key Dependencies or Concentration Risks

Dependence on reimbursements from government payers (Medicare and Medicaid) and on managed care plans and private insurers for the majority of patient service payments; these programs and contracts are subject to regulatory changes, payment rate updates and policy shifts described in the filing.

Geographic concentration risk due to heavy concentration of facilities in specific states, explicitly including Florida and Texas, making operations sensitive to regulatory, economic, public health and environmental conditions in those states.

Dependence on negotiated managed care contracts and the ability to retain favorable contract terms; managed care contracts are explicitly negotiated and can affect volumes and reimbursement.

Reliance on physician referrals and relationships with employed and affiliated physicians; physicians may terminate affiliations at any time, and physician recruitment and retention are identified as important to utilization and competitive position.

Exposure to payer audits, administrative contractor transitions (MAC transitions) and integrity programs (RACs, UPICs), which can result in payment recoveries, denials and additional costs.

Dependency on state-administered supplemental and state-directed payment arrangements and on the availability and approval of those programs by CMS; these payments are subject to change and periodic CMS approval.

Competitive pressures from other hospitals, physician-owned facilities, not-for-profit and tax-supported entities, freestanding specialty providers and ASCs, which may affect patient volumes and contract negotiations.

Operational risk from compliance and regulatory frameworks (fraud and abuse laws, Stark Law, licensure, accreditation and EMTALA) that could materially affect reimbursement and ability to operate facilities if compliance failures occur.

Profitability

Profit Margins

Earnings Quality

Earnings Quality Analysis

Comparing reported earnings to actual cash generation

Earnings Quality Analysis — Net Income vs Operating Cash Flow (TTM)

HCA Healthcare, Inc.'s trailing twelve-month net income shows a rising trend over the dataset, increasing from about $2.23B in early 2015 to $2.89B in 2016, then to $3.50B in 2019 and $3.75B in 2020, before a notable jump to $6.96B at year-end 2021. By contrast, reported trailing twelve-month operating cash flow in the available series is relatively flat, hovering in the $5.1B$5.7B range from 2015 through early 2018 with a most recent reported level of $5.45B. The gap between net income and operating cash flow widens in the most recent comparable observations, with net income exceeding operating cash flow.

Key inflection points

  • Steady increase in net income through 2020
  • Sharp rise in net income between 2020 and 2021
  • Operating cash flow remained broadly stable across 2015–2018 without a comparable increase

Most recent Net Income (TTM): $6.96B (period end 2021-12-31)

Most recent Operating Cash Flow (TTM): $5.45B (period end 2018-03-31)

The Earnings vs. Cash Flow Gap

Reported earnings (Net Income) doesn't always reflect actual cash generation. Companies use accrual accounting, which recognizes revenue when earned and expenses when incurred—not when cash actually changes hands. This creates timing differences and opportunities for accounting discretion that can mask underlying business health.

Net Income (the "earnings" number) can be influenced by non-cash items like depreciation, stock-based compensation, and changes in accounting estimates.Operating Cash Flow, however, shows the actual cash the business generates from its core operations—a harder number to manipulate.

What to Look For

  • Consistent Alignment: High-quality earnings show operating cash flow tracking closely with or exceeding net income over time. This indicates the company is actually collecting cash from its reported profits.
  • Warning Sign - Divergence: If net income consistently exceeds cash flow, the company may be reporting earnings that aren't translating to cash. This could indicate aggressive revenue recognition, growing receivables that may not be collected, or inventory building up.
  • Positive Sign - Cash Exceeds Earnings: When cash flow exceeds net income, it often reflects conservative accounting (like accelerated depreciation) or strong working capital management. This is generally a sign of high earnings quality.
  • Quarterly Volatility is Normal: Some variation is expected due to timing of collections, seasonal factors, and one-time items. Focus on the trend over multiple quarters rather than any single period.

Key Insight: Companies with durable competitive advantages typically show operating cash flow that meets or exceeds net income over time, demonstrating they convert accounting profits into actual cash that can be returned to shareholders or reinvested in the business.

Return on Equity

Return on Equity (ROE)

Measuring management's efficiency at generating profits from shareholder capital

Return on Equity (ROE) Analysis

HCA Healthcare, Inc.'s trailing twelve-month return on equity was relatively steady in the historical sample, generally clustering between about 7.9% and 10.3% across the 2015–2019 and 2016 quarterly observations. ROE remained near the low end of that range through 2019 (7.9%) and 2020 (8.4%), indicating limited variation in the earlier periods shown.

The most notable inflection is a pronounced increase in the latest period: ROE rose from 8.4% for the year ending to 14.1% for the year ending , a 5.7 percentage-point increase. The most recent trailing twelve-month ROE observed was 14.1% as of .

The Gold Standard of Profitability

Return on Equity (ROE) is a powerful measure of how effectively a company's management is using the money shareholders have invested. Calculated by dividing Net Income by Shareholders' Equity, it reveals how much profit is generated for every dollar of equity capital.

A consistently high ROE (typically above 15-20%) is often the signature of a "quality" business with a durable competitive advantage. It indicates that the company can generate high returns on its own capital, which it can then reinvest at these high rates to compound value over time.

What to Look For:

  • Consistency: Look for an ROE that is stable or rising over time. Erratic ROE can signal cyclicality or inconsistent management.
  • Quality vs. Leverage: While a high ROE is generally positive, it can sometimes be artificially inflated by high debt (leverage). Always cross-reference ROE with the company's Debt-to-Equity ratio to ensure the profitability is coming from operational excellence rather than excessive borrowing.
  • Comparison: ROE is most meaningful when compared against industry peers or the company's own historical average.
HCA Healthcare, Inc. (HCA) Return on Equity (ROE) historical trend analysis. Quarterly chart showing the company's return on equity over time, reflecting management's efficiency in using shareholder capital.

Capital Allocation & Cash Flow

Capital Strategy

Strategic Capital Allocation

How the company generates and deploys its cash

Strategic Capital Allocation — Cash Flow Allocation Trend (TTM)

HCA Healthcare, Inc.'s financing cash flow is consistently negative in the provided history and shows a clear recent increase in outflow. Financing CF TTM was reported at -$4.58B for the 2024 period and moves to -$8.55B for the period ending 2025-12-31, representing the most pronounced inflection in the dataset; earlier financing TTM figures ranged from -$2.00B (2013) to about -$6.67B (2021).

Operating Cash Flow (TTM)

Operating cash flow TTM values in the dataset are limited to 2015–2018, where operating CF was relatively stable in the $4.7B$5.7B range, with the latest reported operating CF TTM of $5.45B (period ending 2018-03-31).

Investing Cash Flow (TTM)

Investing cash flow TTM is not present in the provided data.

Recent Cash Flows

  • Most recent Operating Cash Flow (TTM): $5.45B (period ending 2018-03-31)
  • Most recent Investing Cash Flow (TTM): not provided
  • Most recent Financing Cash Flow (TTM): -$8.55B (period ending 2025-12-31)

Understanding Company Strategy

Capital allocation refers to how management decides to spend and invest the company's cash. Analyzing the three primary categories of cash flow reveals a company's true operational strategy:

  • Operating Cash Flow: The engine of the business. This shows how much cash is generated from core operations. Sustainable businesses should ideally fund their growth and shareholder returns primarily from this source.
  • Investing Cash Flow: The future of the business. This includes spending on new equipment, R&D, and acquisitions. Consistent negative values are normal for growing companies as they reinvest in their future.
  • Financing Cash Flow: The funding of the business. This reflects capital raising (issuing stock or debt) versus returning capital to shareholders (dividends and buybacks) or repaying debt.

What to look for: Is the company bootstrapping (funding growth solely from operating cash)? Are they borrowing to fund aggressive expansion or dividends? Or are they capital raising by issuing new shares, potentially diluting your ownership? A healthy, mature company typically generates strong operating cash, moderately invests in growth, and returns the surplus to shareholders through financing activities.

HCA Healthcare, Inc. (HCA) cash flow allocation analysis. Quarterly chart displaying the three pillars of cash flow: net cash from operating activities, investing activities, and financing activities, providing insight into the company's capital allocation strategy.

Balance Sheet

Book Value per Share

Book Value per Share

Net assets attributable to each share — the accounting floor of intrinsic value

Why Book Value per Share Matters

Book value per share is the net worth of the company — total assets minus total liabilities — divided by shares outstanding (split-adjusted). It represents the theoretical liquidation value per share if every asset were sold and every liability repaid at balance-sheet carrying values. It is the accounting foundation upon which much of equity valuation is built.

A steadily rising book value per share is one of the most reliable signals of compounding wealth creation. It means the company is retaining earnings and building net worth faster than it is returning capital or eroding it. Warren Buffett famously tracked Berkshire Hathaway's book value per share for decades as his primary measure of intrinsic value growth.

Context is essential. Asset-heavy businesses (banks, manufacturers, utilities) should be judged by book value more directly than asset-light businesses (software, consumer brands), where intangible assets like intellectual property and customer loyalty may far exceed their balance-sheet carrying values. A company trading at a large premium to book value is not necessarily overvalued — it may simply possess competitive advantages that accounting rules do not capture. Conversely, a declining book value per share — especially over multiple years — is a serious warning sign of capital destruction.

HCA Healthcare, Inc. (HCA) book value per share trend showing historical net asset value per share over time, split-adjusted.

Debt to Equity

Debt-to-Equity Ratio

How much of the company is financed by debt versus shareholders' equity

Reading the Debt-to-Equity Ratio

The debt-to-equity (D/E) ratio compares total financial debt to shareholders' equity. A ratio of 1.0 means the company has borrowed one dollar for every dollar of equity; a ratio of 2.0 means it has borrowed twice as much as it owns. Financial leverage amplifies both returns and risk: in good times, debt turbocharges equity returns; in bad times, it accelerates losses and can threaten solvency.

Trends matter more than a single number. A rising D/E ratio can mean the company is taking on debt to fund growth — potentially value-creating if returns exceed the cost of capital. But it can also mean equity is being eroded through losses or that the business is borrowing simply to sustain operations. A falling D/E ratio generally reflects strengthening financial health: earnings are being retained, debt maturities are being paid down, or both.

Industry norms vary enormously. Capital-intensive sectors (utilities, real estate, financials) routinely carry high D/E ratios that would be alarming in, say, a technology company. Always compare against sector peers. As a rough rule of thumb, a D/E above 2× in a cyclical business warrants careful scrutiny of interest coverage and refinancing risk.

HCA Healthcare, Inc. (HCA) debt-to-equity ratio trend showing the historical balance between financial leverage and shareholders' equity.

Current Ratio

Current Ratio

Short-term liquidity — can the company cover its near-term obligations?

Liquidity: Can the Business Pay Its Bills?

The current ratio is calculated as current assets divided by current liabilities. A ratio of 1.5 means the company has $1.50 of short-term assets — cash, receivables, inventory — for every $1.00 of obligations due within the next twelve months. It is the most direct measure of near-term financial resilience: can the business meet its obligations without needing to raise new capital or sell long-term assets at a discount?

A ratio above 1.0 is generally healthy, meaning current assets exceed current liabilities. A ratio consistently above 2.0 may indicate the company is holding excess cash or inventory that could be deployed more productively. A ratio below 1.0 is a warning sign — the company is relying on future cash generation or external financing to cover its near-term obligations, which is manageable in normal conditions but dangerous during a downturn.

Trends and context matter.A declining current ratio isn't always alarming — highly efficient businesses (e.g., large retailers with reliable daily cash flows) often run leaner balance sheets intentionally. Conversely, a rapidly rising current ratio can signal slowing sales causing inventory to build, or customers taking longer to pay. Always compare the trend against industry peers and cross-reference with the cash flow statement to assess whether the business is genuinely liquid or just holding non-cash current assets.

HCA Healthcare, Inc. (HCA) current ratio trend showing the ratio of current assets to current liabilities over time, a measure of short-term liquidity.

Valuation

PE Ratio

Price-to-Earnings (PE) Ratio Trend

How much the market is paying for each dollar of company earnings

Price-to-Earnings (PE) Ratio

HCA Healthcare, Inc.'s trailing twelve-month P/E has moved lower in the most recent reported years, falling from 10.3x at 2020-12-31 (and 9.9x at 2019-12-31) to 8.7x at 2021-12-31. That recent sequence shows a contraction in the multiple over the last one-to-two reporting years in the dataset.

Historical Range

Over the full history provided, the P/E has ranged from a low of 2.1x at 2011-12-31 to highs near 10.0x (2015-06-30) and 10.3x (2020-12-31), with a notable trough at 6.1x on 2016-12-31 amid volatility in 2015–2016. The most recent Price-to-Earnings ratio was 8.7x as of 2021-12-31.

What Is the PE Ratio?

The Price-to-Earnings (PE) ratio is one of the most widely used valuation metrics in investing. It divides the current stock price by the company's earnings per share (EPS), revealing how much investors are willing to pay for each dollar of earnings. A high PE can signal that the market expects strong future growth, while a low PE may suggest undervaluation—or reflect genuine concerns about the company's prospects.

Context matters:PE ratios vary significantly across industries. High-growth technology companies routinely trade at PE ratios above 30x or 40x, while mature, low-growth sectors like utilities or financials often trade closer to 10–15x. Always compare a company's PE to its own history and its industry peers, not just an absolute number.

What to Look For:

  • Expanding PE (Re-rating):If the PE is rising while earnings are also growing, the market is assigning increasing confidence in the company's future. If PE rises while earnings stagnate, it may signal speculative excess.
  • Contracting PE (De-rating): A falling PE can indicate the market is losing confidence in growth prospects. If earnings grow but the PE shrinks, total returns may be muted.
  • Negative PE: When a company is loss-making, the PE ratio is negative or undefined. In these cases, investors typically use other metrics such as Price-to-Sales (P/S) or EV/EBITDA.
  • Spikes and Troughs: Sudden PE spikes often occur when earnings temporarily collapse (making the divisor small) rather than when the stock price surges. Context is key.

Key Insight:The PE ratio is a snapshot of market sentiment and expectations. Tracking it over time alongside earnings trends reveals whether the market's valuation has expanded or contracted—and whether that change is justified by fundamentals.

HCA Healthcare, Inc. (HCA) Price-to-Earnings (PE) ratio historical trend analysis. Quarterly chart showing how the market has valued the company's earnings over time.